DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1 - PubMed (original) (raw)

. 2000 Dec 1;60(23):6581-4.

Affiliations

PMID: 11118037

DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1

I O Ng et al. Cancer Res. 2000.

Abstract

We investigated the expression and deletion of DLC-1 (frequently deleted in liver cancer gene), first reported in 1998 and having a high homology with rat p122RhoGAP in hepatocellular carcinoma (HCC). Six (20%) of 30 human HCC samples and 2 (40%) of 5 HCC cell lines were found to have no detectable DLC-1 expression by reverse transcription-PCR. Homozygous DLC-1 deletion was detected by Southern blotting in two of six HCC samples and in both HCC cell lines with no DLC-1 expression. Transfection of DLC-1 into 5 HCC cell lines (two with DLC-1 deletion and three with intact DLC-1) showed significant growth inhibition in these two HCC cell lines with deleted DLC-1 with both 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and colony formation assays but not in three other HCC cell lines with intact DLC-1. Our findings suggest that DLC-1 may play an important role in hepatocarcinogenesis.

PubMed Disclaimer

Cited by

Effect of FAK, DLC-1 gene expression on OVCAR-3 proliferation.
Liu H, Shi H, Hao Y, Zhao G, Yang X, Wang Y, Li M, Liu M. Liu H, et al. Mol Biol Rep. 2012 Dec;39(12):10665-70. doi: 10.1007/s11033-012-1956-6. Epub 2012 Oct 19. Mol Biol Rep. 2012. PMID: 23079702
Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model.
Chen B, Xu M, Xu M. Chen B, et al. Oncol Lett. 2019 Nov;18(5):5600-5606. doi: 10.3892/ol.2019.10871. Epub 2019 Sep 16. Oncol Lett. 2019. PMID: 31612067 Free PMC article.
Uncovering the rare variants of DLC1 isoform 1 and their functional effects in a Chinese sporadic congenital heart disease cohort.
Lin B, Wang Y, Wang Z, Tan H, Kong X, Shu Y, Zhang Y, Huang Y, Zhu Y, Xu H, Wang Z, Wang P, Ning G, Kong X, Hu G, Hu L. Lin B, et al. PLoS One. 2014 Feb 28;9(2):e90215. doi: 10.1371/journal.pone.0090215. eCollection 2014. PLoS One. 2014. PMID: 24587289 Free PMC article.
Solution structure of the phosphotyrosine binding (PTB) domain of human tensin2 protein in complex with deleted in liver cancer 1 (DLC1) peptide reveals a novel peptide binding mode.
Chen L, Liu C, Ko FC, Xu N, Ng IO, Yam JW, Zhu G. Chen L, et al. J Biol Chem. 2012 Jul 27;287(31):26104-14. doi: 10.1074/jbc.M112.360206. Epub 2012 May 29. J Biol Chem. 2012. PMID: 22645138 Free PMC article.
Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection.
Chan KY, Wong CM, Kwan JS, Lee JM, Cheung KW, Yuen MF, Lai CL, Poon RT, Sham PC, Ng IO. Chan KY, et al. PLoS One. 2011;6(12):e28798. doi: 10.1371/journal.pone.0028798. Epub 2011 Dec 8. PLoS One. 2011. PMID: 22174901 Free PMC article.

DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1 - PubMed (original) (raw)